About this Journal Submit a Manuscript Table of Contents
ISRN Neurology
Volume 2011 (2011), Article ID 394678, 29 pages
http://dx.doi.org/10.5402/2011/394678
Research Article

The Fox and the Rabbits—Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease

PolygenicPathways, Flat 4, 20 Upper Maze Hill, St Leonards-on-Sea, East Sussex, TN38 0LG, UK

Received 13 March 2011; Accepted 20 April 2011

Academic Editor: A. Conti

Copyright © 2011 C. J. Carter. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Bertram and R. E. Tanzi, “Alzheimer's disease: one disorder, too many genes?” Human Molecular Genetics, vol. 13, no. 1, pp. R135–R141, 2004.
  2. S. Cichon, N. Craddock, M. Daly et al., “Genomewide association studies: history, rationale, and prospects for psychiatric disorders,” American Journal of Psychiatry, vol. 166, no. 5, pp. 540–556, 2009. View at Publisher · View at Google Scholar · View at PubMed
  3. V. Vacic, S. McCarthy, D. Malhotra et al., “Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia,” Nature, vol. 471, no. 7339, pp. 499–503, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. B. Bondy, “Genetics in psychiatry: are the promises met?” The World Journal of Biological Psychiatry, vol. 12, no. 2, pp. 81–88, 2011.
  5. H. L. Li, S. S. Shi, Q. H. Guo, et al., “PICALM and CR1 variants are not associated with sporadic Alzheimer's disease in Chinese patients”.
  6. G. Jun, A. C. Naj, G. W. Beecham et al., “Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes,” Archives of Neurology, vol. 67, no. 12, pp. 1473–1484, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. P. J. Talmud, N. Yiannakouris, and S. E. Humphries, “Lipoprotein association studies: taking stock and moving forward,” Current Opinion in Lipidology, vol. 22, no. 2, pp. 106–112, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. A. E. Handel, A. J. Williamson, G. Disanto, L. Handunnetthi, G. Giovannoni, and S. V. Ramagopalan, “An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis,” PLoS ONE, vol. 5, no. 9, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. G. Ingram, J. J. Bugert, S. Loveless, and N. P. Robertson, “Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity,” European Journal of Neurology, vol. 17, no. 11, pp. 1386–1389, 2010. View at Publisher · View at Google Scholar · View at PubMed
  10. D. Franciotta, A. Bestetti, S. Sala et al., “Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum,” Acta Neurologica Belgica, vol. 109, no. 4, pp. 277–282, 2009.
  11. A. Papassotiropoulos, M. A. Wollmer, M. Tsolaki et al., “A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease,” Journal of Clinical Psychiatry, vol. 66, no. 7, pp. 940–947, 2005.
  12. X. Wu, J. Gu, H. B. Grossman et al., “Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes,” American Journal of Human Genetics, vol. 78, no. 3, pp. 464–479, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. C. J. Carter, “Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades,” Neurochemistry International, vol. 52, no. 6, pp. 920–934, 2008. View at Publisher · View at Google Scholar · View at PubMed
  14. C. J. Carter, “Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii,” Schizophrenia bulletin, vol. 35, no. 6, pp. 1163–1182, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. H. Hemilä and J. Kaprio, “Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C,” Nutrition Journal, vol. 7, no. 1, article 33, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. H. Hemilä and J. Kaprio, “Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C,” American Journal of Epidemiology, vol. 169, no. 8, pp. 946–953, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. H. Hemilä and J. Kaprio, “Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking,” Age and Ageing, vol. 40, no. 2, pp. 215–220, 2011. View at Publisher · View at Google Scholar · View at PubMed
  18. I. L. Ferreira, R. Resende, E. Ferreiro, A. C. Rego, and C. F. Pereira, “Multiple defects in energy metabolism in Alzheimer's disease,” Current Drug Targets, vol. 11, no. 10, pp. 1193–1206, 2010.
  19. M. Facheris, S. Beretta, and C. Ferrarese, “Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy?” Journal of Alzheimer's Disease, vol. 6, no. 2, pp. 177–184, 2004.
  20. S. Goto, H. Bono, H. Ogata et al., “Organizing and computing metabolic pathway data in terms of binary relations,” Pacific Symposium on Biocomputing, pp. 175–186, 1997.
  21. J. E. Larsen, O. Lund, and M. Nielsen, “Improved method for predicting linear B-cell epitopes,” Immunome Research, vol. 2, article 2, 2006.
  22. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997. View at Publisher · View at Google Scholar
  23. M. Nielsen, C. Lundegaard, O. Lund, and C. Keşmir, “The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage,” Immunogenetics, vol. 57, no. 1-2, pp. 33–41, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. A. Takaoka and S. Shinohara, “DNA sensors in innate immune system,” Uirusu, vol. 58, no. 1, pp. 37–46, 2008. View at Publisher · View at Google Scholar
  25. S. Chattopadhyay, J. T. Marques, M. Yamashita et al., “Viral apoptosis is induced by IRF-3-mediated activation of Bax,” EMBO Journal, vol. 29, no. 10, pp. 1762–1773, 2010. View at Publisher · View at Google Scholar · View at PubMed
  26. L. S. Murillo, S. A. Morré, and A. S. Peña, “Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response,” Drugs of Today, vol. 39, no. 6, pp. 415–438, 2003. View at Publisher · View at Google Scholar
  27. A. H. Oijen, M. L. Verhulst, H. M. Roelofs, W. H. Peters, W. A. de Boer, and J. B. Jansen, “Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa,” Japanese Journal of Cancer Research, vol. 92, no. 12, pp. 1329–1334, 2001.
  28. A. Fraternale, M. F. Paoletti, A. Casabianca et al., “GSH and analogs in antiviral therapy,” Molecular Aspects of Medicine, vol. 30, no. 1-2, pp. 99–110, 2009. View at Publisher · View at Google Scholar · View at PubMed
  29. Y. N. Zhang and K. M. Duan, “Glutathione exhibits antibacterial activity and increases tetracycline efficacy against Pseudomonas aeruginosa,” Science in China Series C, vol. 52, no. 6, pp. 501–505, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. P. L. Páez, M. C. Becerra, and I. Albesa, “Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus,” FEMS Microbiology Letters, vol. 303, no. 1, pp. 101–105, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. M. Nakayama, J. Hisatsune, E. Yamasaki et al., “Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway,” Journal of Biological Chemistry, vol. 284, no. 3, pp. 1612–1619, 2009. View at Publisher · View at Google Scholar · View at PubMed
  32. R. Takenaka, K. Yokota, K. Ayada et al., “Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells,” Microbiology, vol. 150, no. 12, pp. 3913–3922, 2004. View at Publisher · View at Google Scholar · View at PubMed
  33. C. J. Carter, “Alzheimer's disease plaques and tangles: cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction,” Neurochemistry International, vol. 58, no. 3, pp. 301–320, 2011. View at Publisher · View at Google Scholar · View at PubMed
  34. D. R. Lees, “Genetic control of the melanic form insularia of the peppered moth biston betularia (L.),” Nature, vol. 220, no. 5173, pp. 1249–1250, 1968. View at Publisher · View at Google Scholar
  35. J. C. Figueiredo, J. P. Lewinger, C. Song, et al., “Genotype-environment interactions in MSS/MSI-low colorectal cancer: results from a genome-wide association study,” Cancer Epidemiology, Biomarkers & Prevention, vol. 20, p. 758, 2011. View at Publisher · View at Google Scholar · View at PubMed
  36. K. Oexle and T. Meitinger, “Sampling GWAS subjects from risk populations,” Genetic Epidemiology, vol. 35, no. 3, pp. 148–153, 2011. View at Publisher · View at Google Scholar · View at PubMed
  37. H. Aschard, D. B. Hancock, S. J. London, and P. Kraft, “Genome-wide meta-analysis of joint tests for genetic and gene-environment interaction effects,” Human Heredity, vol. 70, no. 4, pp. 292–300, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. R. F. Itzhaki, W. R. Lin, D. Shang, G. K. Wilcock, B. Faragher, and G. A. Jamieson, “Herpes simplex virus type 1 in brain and risk of Alzheimer's disease,” Lancet, vol. 349, no. 9047, pp. 241–244, 1997. View at Publisher · View at Google Scholar
  39. D. S. Goodman, “Plasma retinol-binding protein,” Annals of the New York Academy of Sciences, vol. 348, pp. 378–390, 1980.
  40. Y. Liang, S. Lin, T. P. Beyer et al., “A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes,” Journal of Neurochemistry, vol. 88, no. 3, pp. 623–634, 2004. View at Publisher · View at Google Scholar
  41. R. Schindler and A. Klopp, “Transport of esterified retinol in fasting human blood,” International Journal for Vitamin and Nutrition Research, vol. 56, no. 1, pp. 21–27, 1986.
  42. H. M. Naylor and M. E. Newcomer, “The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP,” Biochemistry, vol. 38, no. 9, pp. 2647–2653, 1999. View at Publisher · View at Google Scholar · View at PubMed
  43. F. Boukhtouche, J. Mariani, and A. Tedgui, “The "CholesteROR" protective pathway in the vascular system,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 637–643, 2004. View at Publisher · View at Google Scholar · View at PubMed
  44. M. M. Sousa, L. Berglund, and M. J. Saraiva, “Transthyretin in high density lipoproteins: association with apolipoprotein A-I,” Journal of Lipid Research, vol. 41, no. 1, pp. 58–65, 2000.
  45. S. Smeland, S. O. Kolset, M. Lyon, K. R. Norum, and R. Blomhoff, “Binding of perlecan to transthyretin in vitro,” Biochemical Journal, vol. 326, no. 3, pp. 829–836, 1997.
  46. T. C. Kiorpes, R. S. Anderson, and G. Wolf, “Effect of vitamin A deficiency on glycosylation of rat serum α-macroglobulin,” Journal of Nutrition, vol. 111, no. 12, pp. 2059–2068, 1981.
  47. R. P. Koldamova, I. M. Lefterov, M. D. Ikonomovic et al., “22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 13244–13256, 2003. View at Publisher · View at Google Scholar · View at PubMed
  48. A. During and E. H. Harrison, “Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells,” Journal of Lipid Research, vol. 48, no. 10, pp. 2283–2294, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. E. Reboul, D. Trompier, M. Moussa, et al., “ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice,” The American Journal of Clinical Nutrition, vol. 89, no. 1, pp. 177–184, 2009.
  50. I. C. Gaemers, A. M. M. Van Pelt, A. P. N. Themmen, and D. G. De Rooij, “Isolation and characterization of all-trans-retinoic acid-responsive genes in the rat testis,” Molecular Reproduction and Development, vol. 50, no. 1, pp. 1–6, 1998. View at Publisher · View at Google Scholar
  51. C. R. Morales and M. D. Griswold, “Variations in the level of transferrin and SGP-2 mRNAs in Sertoli cells of vitamin A-deficient rats,” Cell and Tissue Research, vol. 263, no. 1, pp. 125–130, 1991. View at Publisher · View at Google Scholar
  52. S. K. Lee, H. S. Choi, M. R. Song, M. O. Lee, and J. W. Lee, “Estrogen receptor, a common interaction partner for a subset of nuclear receptors,” Molecular Endocrinology, vol. 12, no. 8, pp. 1184–1192, 1998.
  53. M. A. Adly, “Expression of the carrier protein transthyretin and its receptor megalin in human skin: preliminary findings,” British Journal of Dermatology, vol. 162, no. 1, pp. 213–215, 2010. View at Publisher · View at Google Scholar · View at PubMed
  54. E. I. Christensen, J. O. Moskaug, H. Vorum et al., “Evidence for an essential role of megalin in transepithelial transport of retinol,” Journal of the American Society of Nephrology, vol. 10, no. 4, pp. 685–695, 1999.
  55. W. Ambroziak, G. Izaguirre, and R. Pietruszko, “Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney,” Journal of Biological Chemistry, vol. 274, no. 47, pp. 33366–33373, 1999. View at Publisher · View at Google Scholar
  56. J. Pinaire, W. Y. Chou, M. Morton et al., “Identification of a retinoid receptor response element in the human aldehyde dehydrogenase-2 promoter,” Alcoholism, vol. 27, no. 12, pp. 1860–1866, 2003. View at Publisher · View at Google Scholar · View at PubMed
  57. Y. Wang, N. Kumar, C. Crumbley, P. R. Griffin, and T. P. Burris, “A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol),” Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 917–923, 2010. View at Publisher · View at Google Scholar · View at PubMed
  58. H. Chen and M. R. Juchau, “Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro,” Biochemical Journal, vol. 336, no. 1, pp. 223–226, 1998.
  59. D. E. Breithaupt, A. Bamedi, and U. Wirt, “Carotenol fatty acid esters: easy substrates for digestive enzymes?” Comparative Biochemistry and Physiology—B, vol. 132, no. 4, pp. 721–728, 2002. View at Publisher · View at Google Scholar
  60. E. H. Harrison, “Lipases and carboxylesterases: possible roles in the hepatic utilization of vitamin A,” Journal of Nutrition, vol. 130, no. 2, pp. 340S–344S, 2000.
  61. A. Woods, C. G. James, G. Wang, H. Dupuis, and F. Beier, “Control of chondrocyte gene expression by actin dynamics: a novel role of cholesterol/Ror-α signalling in endochondral bone growth,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 3497–3516, 2009. View at Publisher · View at Google Scholar · View at PubMed
  62. X. Gong, S. W. Tsai, B. Yan, and L. P. Rubin, “Cooperation between MEF2 and PPARγ in human intestinal β,β-carotene 15, 15′-monooxygenase gene expression,” BMC Molecular Biology, vol. 7, article 7, 2006. View at Publisher · View at Google Scholar · View at PubMed
  63. D. R. Johnson, J. M. Lovett, M. Hirsch, F. Xia, and J. D. Chen, “NuRD complex component Mi-2beta binds to and represses RORgamma-mediated transcriptional activation,” Biochemical and Biophysical Research Communications, vol. 318, no. 3, pp. 714–718, 2004.
  64. X. H. Zhang, B. Zheng, M. Han, S. B. Miao, and J. K. Wen, “Synthetic retinoid Am80 inhibits interaction of KLF5 with RARα through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells,” FEBS Letters, vol. 583, no. 8, pp. 1231–1236, 2009. View at Publisher · View at Google Scholar · View at PubMed
  65. P. McNamara, S. B. Seo, R. D. Rudic, A. Sehgal, D. Chakravarti, and G. A. FitzGerald, “Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock,” Cell, vol. 105, no. 7, pp. 877–889, 2001. View at Publisher · View at Google Scholar
  66. C. Crumbley, Y. Wang, D. J. Kojetin, and T. P. Burris, “Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene,” The Journal of Biological Chemistry, vol. 285, no. 46, pp. 35386–35392, 2010.
  67. R. Pavri, B. Lewis, T. K. Kim et al., “PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator,” Molecular Cell, vol. 18, no. 1, pp. 83–96, 2005. View at Publisher · View at Google Scholar · View at PubMed
  68. M. Gianni', A. Boldetti, V. Guarnaccia et al., “Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARα and PML-RARα,” Cancer Research, vol. 69, no. 3, pp. 1016–1026, 2009. View at Publisher · View at Google Scholar · View at PubMed
  69. T. Kakizawa, T. Miyamoto, K. Ichikawa et al., “Functional interaction between Oct-1 and retinoid X receptor,” Journal of Biological Chemistry, vol. 274, no. 27, pp. 19103–19108, 1999. View at Publisher · View at Google Scholar
  70. A. Gorla-Bajszczak, C. Juge-Aubry, A. Pernin, A. G. Burger, and C. A. Meier, “Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR,” Molecular and Cellular Endocrinology, vol. 147, no. 1-2, pp. 37–47, 1999.
  71. T. Wang, J. Xu, X. Yu, R. Yang, and Z. C. Han, “Peroxisome proliferator-activated receptor gamma in malignant diseases,” Critical Reviews in Oncology / Hematology, vol. 58, no. 1, pp. 1–14, 2006. View at Publisher · View at Google Scholar · View at PubMed
  72. G. E. O. Muscat, L. Mynett-Johnson, D. Dowhan, M. Downes, and R. Griggs, “Activation of myoD gene transcription by 3,5,3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors,” Nucleic Acids Research, vol. 22, no. 4, pp. 583–591, 1994.
  73. D. Zhu, C. Wang, B. Liu, Y. Wu, L. Zhong, and C. Wang, “Interaction between nuclear localization signal-retinoic acid receptor alpha and Ubiquilin 1,” Journal of Central South University, vol. 35, no. 7, pp. 649–654, 2010.
  74. N. J. Koszewski, J. Herberth, and H. H. Malluche, “Retinoic acid receptor gamma 2 interactions with vitamin D response elements,” Journal of Steroid Biochemistry and Molecular Biology, vol. 120, no. 4-5, pp. 200–207, 2010. View at Publisher · View at Google Scholar · View at PubMed
  75. Y. Gao and S. W. Pimplikar, “The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 14979–14984, 2001. View at Publisher · View at Google Scholar · View at PubMed
  76. A. Koryakina, J. Aeberhard, S. Kiefer, M. Hamburger, and P. Küenzi, “Regulation of secretases by all-trans-retinoic acid,” FEBS Journal, vol. 276, no. 9, pp. 2645–2655, 2009. View at Publisher · View at Google Scholar · View at PubMed
  77. S. N. Sarkar and H. K. Das, “Regulatory roles of presenilin-1 and nicastrin in neuronal differentiation during in vitro neurogenesis,” Journal of Neurochemistry, vol. 87, no. 2, pp. 333–343, 2003. View at Publisher · View at Google Scholar
  78. F. Flood, E. Sundström, E. B. Samuelsson et al., “Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line,” Neurochemistry International, vol. 44, no. 7, pp. 487–496, 2004. View at Publisher · View at Google Scholar
  79. K. Uemura, N. Kitagawa, R. Kohno et al., “Presenilin 1 mediates retinoic acid-induced differentiation of SH-SY5Y cells through facilitation of Wnt signaling,” Journal of Neuroscience Research, vol. 73, no. 2, pp. 166–175, 2003. View at Publisher · View at Google Scholar · View at PubMed
  80. R. Kitching, S. Qi, V. Li, A. Raouf, C. P. H. Vary, and A. Seth, “Coordinate gene expression patterns during osteoblast maturation and retinoic acid treatment of MC3T3-E1 cells,” Journal of Bone and Mineral Metabolism, vol. 20, no. 5, pp. 269–280, 2002. View at Publisher · View at Google Scholar · View at PubMed
  81. H. S. Kuo, F. N. Hsu, M. C. Chiang et al., “The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line,” Chinese Journal of Physiology, vol. 52, no. 1, pp. 23–30, 2009. View at Publisher · View at Google Scholar
  82. A. Jämsä, K. Hasslund, R. F. Cowburn, A. Bäckström, and M. Vasänge, “The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation,” Biochemical and Biophysical Research Communications, vol. 319, no. 3, pp. 993–1000, 2004. View at Publisher · View at Google Scholar · View at PubMed
  83. M. C. Monteiro, B. Wdziekonski, P. Villageois et al., “Commitment of mouse embryonic stem cells to the adipocyte lineage requires retinoic acid receptor β and active GSK3,” Stem Cells and Development, vol. 18, no. 3, pp. 457–463, 2009. View at Publisher · View at Google Scholar · View at PubMed
  84. N. Haque, T. Tanaka, K. Iqbal, and I. Grundke-Iqbal, “Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells,” Brain Research, vol. 838, no. 1-2, pp. 69–77, 1999. View at Publisher · View at Google Scholar
  85. M. K. Oeff, H. Seltmann, N. Hiroi et al., “Differential regulation of toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes,” Dermatology, vol. 213, no. 3, p. 266, 2006. View at Publisher · View at Google Scholar · View at PubMed
  86. C. M. Bliss Jr., D. T. Golenbock, S. Keates, J. K. Linevsky, and C. P. Kelly, “Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes,” Infection and Immunity, vol. 66, no. 11, pp. 5357–5363, 1998.
  87. Y. Ma, Q. Chen, and A. C. Ross, “Retinoic acid and polyriboinosinic: polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations,” Journal of Immunology, vol. 174, no. 12, pp. 7961–7969, 2005.
  88. S. U. Gorr and M. Abdolhosseini, “Antimicrobial peptides and periodontal disease,” Journal of Clinical Periodontology, vol. 38, supplement 11, pp. 126–141, 2011. View at Publisher · View at Google Scholar · View at PubMed
  89. A. Yen, D. M. Lin, T. J. Lamkin, and S. Varvayanis, “Retinoic acid, bromodeoxyuridine, and the Δ205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation,” In Vitro Cellular and Developmental Biology, vol. 40, no. 7, pp. 216–241, 2004.
  90. P. Desreumaux, L. Dubuquoy, S. Nutten, et al., “Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies,” The Journal of Experimental Medicine, vol. 193, no. 7, pp. 827–838, 2001. View at Publisher · View at Google Scholar
  91. T. Saitoh, A. Tun-Kyi, A. Ryo et al., “Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1,” Nature Immunology, vol. 7, no. 6, pp. 598–605, 2006. View at Publisher · View at Google Scholar · View at PubMed
  92. R. Hertz, M. Seckbach, M. M. Zakin, and J. Bar-Tana, “Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators,” Journal of Biological Chemistry, vol. 271, no. 1, pp. 218–224, 1996. View at Publisher · View at Google Scholar
  93. B. Gu, J. Miao, Y. Fa, J. Lu, and S. Zou, “Retinoic acid attenuates lipopolysaccharide-induced inflammatory responses by suppressing TLR4/NF-κB expression in rat mammary tissue,” International Immunopharmacology, vol. 10, no. 7, pp. 799–805, 2010. View at Publisher · View at Google Scholar · View at PubMed
  94. S. Murthy, E. Born, S. N. Mathur, and F. J. Field, “LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells,” Journal of Lipid Research, vol. 43, no. 7, pp. 1054–1064, 2002. View at Publisher · View at Google Scholar
  95. U. Lind, T. Nilsson, J. McPheat, et al., “Identification of the human ApoAV gene as a novel RORalpha target gene,” Biochemical and Biophysical Research Communications, vol. 330, no. 1, pp. 233–241, 2005.
  96. R. Moreno, F. Perez-Jimenez, C. Marin et al., “A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T > C modulates postprandial lipoprotein metabolism,” Atherosclerosis, vol. 189, no. 1, pp. 163–168, 2006. View at Publisher · View at Google Scholar · View at PubMed
  97. D. Kardassis, A. Roussou, P. Papakosta, K. Boulias, I. Talianidis, and V. I. Zannis, “Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids,” Biochemical Journal, vol. 372, no. 2, pp. 291–304, 2003. View at Publisher · View at Google Scholar · View at PubMed
  98. P. A. Mak, B. A. Laffitte, C. Desrumaux et al., “Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages: a critical role for nuclear liver X receptors α and β,” Journal of Biological Chemistry, vol. 277, no. 35, pp. 31900–31908, 2002. View at Publisher · View at Google Scholar · View at PubMed
  99. Y. S. Lopez-Boado, M. Klaus, M. I. Dawson, and C. Lopez-Otin, “Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway,” The Journal of Biological Chemistry, vol. 271, no. 50, pp. 32105–32111, 1996.
  100. G. D. Norata, M. Ongari, P. Uboldi, F. Pellegatta, and A. L. Catapano, “Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells,” International Journal of Molecular Medicine, vol. 16, no. 4, pp. 717–722, 2005.
  101. J. Fukuchi, C. Song, A. L. Ko, and S. Liao, “Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors,” Steroids, vol. 68, no. 7-8, pp. 685–691, 2003. View at Publisher · View at Google Scholar
  102. S. Georgala, K. H. Schulpis, I. Potouridou, and H. Papadogeorgaki, “Effects of isotretinoin therapy on lipoprotein (a) serum levels,” International Journal of Dermatology, vol. 36, no. 11, pp. 863–864, 1997.
  103. R. Verani, I. Cappuccio, P. Spinsanti et al., “Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid,” Journal of Neurochemistry, vol. 100, no. 1, pp. 242–250, 2007. View at Publisher · View at Google Scholar · View at PubMed
  104. A. M. Padovani, M. F. Molina, and K. K. Mann, “Inhibition of liver X receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 6, pp. 1228–1236, 2010. View at Publisher · View at Google Scholar · View at PubMed
  105. P. Yang, Z. Liu, H. Wang et al., “Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration,” Life Sciences, vol. 84, no. 13-14, pp. 402–408, 2009. View at Publisher · View at Google Scholar · View at PubMed
  106. M. R. de Oliveira, M. W. S. Oliveira, G. A. Behr, M. A. B. Pasquali, and J. C. F. Moreira, “Increased receptor for advanced glycation endproducts immunocontent in the cerebral cortex of vitamin a-treated rats,” Neurochemical Research, vol. 34, no. 8, pp. 1410–1416, 2009. View at Publisher · View at Google Scholar · View at PubMed
  107. D. P. Gelain, M. A. B. Pasquali, F. F. Caregnato, A. Zanotto-Filho, and J. C. Moreira, “Retinol up-regulates the receptor for advanced glycation endproducts (RAGE) by increasing intracellular reactive species,” Toxicology in Vitro, vol. 22, no. 5, pp. 1123–1127, 2008. View at Publisher · View at Google Scholar · View at PubMed
  108. R. M. Moretti, M. M. Montagnani, A. Sala, M. Motta, and P. Limonta, “Activation of the orphan nuclear receptor RORα counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase,” International Journal of Cancer, vol. 112, no. 1, pp. 87–93, 2004. View at Publisher · View at Google Scholar · View at PubMed
  109. S. van Neerven, T. Regen, D. Wolf et al., “Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid,” Journal of Neurochemistry, vol. 114, no. 5, pp. 1511–1526, 2010. View at Publisher · View at Google Scholar · View at PubMed
  110. J. Ko, C. Y. Yun, J. S. Lee, J. H. Kim, and I. S. Kim, “p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells,” Experimental and Molecular Medicine, vol. 39, no. 2, pp. 129–138, 2007.
  111. X. Wang, C. Allen, and M. Ballow, “Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-α from LPS-stimulated monocytes/macrophages,” Journal of Clinical Immunology, vol. 27, no. 2, pp. 193–200, 2007. View at Publisher · View at Google Scholar · View at PubMed
  112. H. Sallmon, V. Hoene, S. C. Weber, and C. Dame, “Differentiation of human SH-SY5Y neuroblastoma cells by all-trans retinoic acid activates the interleukin-18 system,” Journal of Interferon and Cytokine Research, vol. 30, no. 2, pp. 55–58, 2010. View at Publisher · View at Google Scholar · View at PubMed
  113. M. Napolitano, D. Bellavia, M. Maroder et al., “Modulation of cytokine gene expression by thymic lympho-stromal cell to cell interaction: effect of retinoic acid,” Thymus, vol. 24, no. 4, pp. 247–258, 1997. View at Publisher · View at Google Scholar
  114. S. van Neerven, J. Mey, E. A. Joosten et al., “Systemic but not local administration of retinoic acid reduces early transcript levels of pro-inflammatory cytokines after experimental spinal cord injury,” Neuroscience Letters, vol. 485, no. 1, pp. 21–25, 2010. View at Publisher · View at Google Scholar · View at PubMed
  115. D. Wågsäter, K. Jatta, P. Ocaya, J. Dimberg, and A. Sirsjö, “Expression of IL-1β, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells: effects of all-trans-retinoic acid,” Journal of Vascular Research, vol. 43, no. 4, pp. 377–382, 2006. View at Publisher · View at Google Scholar · View at PubMed
  116. B. Gu, Y. Zhu, W. Zhu, J. Miao, Y. Deng, and S. Zou, “Retinoid protects rats against neutrophil-induced oxidative stress in acute experimental mastitis,” International Immunopharmacology, vol. 9, no. 2, pp. 223–229, 2009. View at Publisher · View at Google Scholar · View at PubMed
  117. S. Hashimoto, S. Hayashi, S. Yoshida et al., “Retinoic acid differentially regulates interleukin-1β and interleukin-1 receptor antagonist production by human alveolar macrophages,” Leukemia Research, vol. 22, no. 11, pp. 1057–1061, 1998. View at Publisher · View at Google Scholar
  118. S. Song, B. Guan, T. Men, A. Hoque, R. Lotan, and X. C. Xu, “Antitumor effect of retinoic acid receptor-β associated with suppression of cyclooxygenase-2,” Cancer Prevention Research, vol. 2, no. 3, pp. 274–280, 2009. View at Publisher · View at Google Scholar · View at PubMed
  119. S. J. Lee, E. K. Yang, and S. G. Kim, “Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation,” Molecular Pharmacology, vol. 70, no. 1, pp. 415–425, 2006.
  120. J. Wang, S. Wu, X. Jin et al., “Retinoic acid-inducible gene-i mediates late phase induction of TNF-α by lipopolysaccharide,” Journal of Immunology, vol. 180, no. 12, pp. 8011–8019, 2008.
  121. F. Fidanza, P. Sarchielli, P. Jordan, E. Lüdin, W. Schalch, and B. J. Weimann, “Vitamin nutritional status and immunocompetence of elderly in Perugia (Italy): an epidemiological approach,” International Journal for Vitamin and Nutrition Research, vol. 61, no. 3, pp. 224–231, 1991.
  122. P. Munoz-Canoves, D. P. Vik, and B. F. Tack, “Mapping of a retinoic acid-responsive element in the promoter region of the complement factor H gene,” Journal of Biological Chemistry, vol. 265, no. 33, pp. 20065–20068, 1990.
  123. R. M. Greer, H. M. Buntain, P. J. Lewindon et al., “Vitamin A levels in patients with CF are influenced by the inflammatory response,” Journal of Cystic Fibrosis, vol. 3, no. 3, pp. 143–149, 2004. View at Publisher · View at Google Scholar · View at PubMed
  124. S. Thompson, P. L. Stern, M. Webb, et al., “Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid,” Journal of Cell Science, vol. 72, pp. 37–64, 1984.
  125. F. Lancillotti, V. Giandomenico, E. Affabris, G. Fiorucci, G. Romeo, and G. B. Rossi, “Interferon α-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells,” Cancer Research, vol. 55, no. 14, pp. 3158–3164, 1995.
  126. M. Jinushi, T. Takehara, T. Tatsumi et al., “Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid,” International Journal of Cancer, vol. 104, no. 3, pp. 354–361, 2003. View at Publisher · View at Google Scholar · View at PubMed
  127. E. Czeczuga-Semeniuk, K. Jarzabek, D. Lemancewicz, and S. Wolczynski, “The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel,” Gynecological Endocrinology, vol. 25, no. 5, pp. 287–293, 2009.
  128. H. Odawara, T. Iwasaki, J. Horiguchi et al., “Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) α in breast cancer cells: identification of a novel ROR response element,” Journal of Biological Chemistry, vol. 284, no. 26, pp. 17711–17719, 2009. View at Publisher · View at Google Scholar · View at PubMed
  129. S. Kheirvari, K. Uezu, S. Yamamoto, and Y. Nakaya, “High-dose dietary supplementation of vitamin A induces brain-derived neurotrophic factor and nerve growth factor production in mice with simultaneous deficiency of vitamin A and zinc,” Nutritional Neuroscience, vol. 11, no. 5, pp. 228–234, 2008. View at Publisher · View at Google Scholar · View at PubMed
  130. H. Katsuki, E. Kurimoto, S. Takemori et al., “Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling,” Journal of Neurochemistry, vol. 110, no. 2, pp. 707–718, 2009. View at Publisher · View at Google Scholar · View at PubMed
  131. C. C. Chen, L. W. Hsu, L. T. Huang, and T. L. Huang, “Chronic administration of cyclosporine a changes expression of BDNF and TrkB in rat hippocampus and midbrain,” Neurochemical Research, vol. 35, no. 7, pp. 1098–1104, 2010. View at Publisher · View at Google Scholar · View at PubMed
  132. N. Dey, P. K. De, M. Wang et al., “CSK controls Retinoic Acid Receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation,” Molecular and Cellular Biology, vol. 27, no. 11, pp. 4179–4197, 2007. View at Publisher · View at Google Scholar · View at PubMed
  133. X. Wan, P. Nass, M. D. Duncan, and J. W. Harmon, “Acidic fibroblast growth factor overexpression partially protects 3T3 fibroblasts from apoptosis induced by synthetic retinoid CD437,” Journal of Molecular Medicine, vol. 79, no. 2, pp. 143–148, 2001.
  134. Y. Mao and A. W. M. Lee, “A novel role for Gab2 in bFGF-mediated cell survival during retinoic acid-induced neuronal differentiation,” Journal of Cell Biology, vol. 170, no. 2, pp. 305–316, 2005. View at Publisher · View at Google Scholar · View at PubMed
  135. M. Jaradat, C. Stapleton, S. L. Tilley, et al., “Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 12, pp. 1299–1309, 2006.
  136. E. Bonnet, K. Touyarot, S. Alfos, V. Pallet, P. Higueret, and D. N. Abrous, “Retinoic acid restores adult hippocampal neurogenesis and reverses spatial memory deficit in vitamin A deprived rats,” PLoS ONE, vol. 3, no. 10, Article ID e3487, 2008. View at Publisher · View at Google Scholar · View at PubMed
  137. N. Sidell, Y. Feng, L. Hao et al., “Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells,” Molecular Endocrinology, vol. 24, no. 1, pp. 148–160, 2010. View at Publisher · View at Google Scholar · View at PubMed
  138. M. Zhang, K. Huang, Z. Zhang, et al., “Proteome alterations of cortex and hippocampus tissues in mice subjected to vitamin A depletion”. View at Publisher · View at Google Scholar · View at PubMed
  139. J. Zimny, “Mechanisms that protect against homocysteine toxicity,” Postepy biochemii, vol. 54, no. 1, pp. 91–98, 2008.
  140. Y. Y. Xu, D. Y. Guan, M. Yang, H. Wang, and Z. H. Shen, “All-trans-retinoic acid intensifies endoplasmic reticulum stress in N-acetylglucosaminyltransferase V repressed human hepatocarcinoma cells by perturbing homocysteine metabolism,” Journal of Cellular Biochemistry, vol. 109, no. 3, pp. 468–477, 2010. View at Publisher · View at Google Scholar · View at PubMed
  141. I. Pascual, I. M. Larrayoz, and I. R. Rodriguez, “Retinoic acid regulates the human methionine sulfoxide reductase A (MSRA) gene via two distinct promoters,” Genomics, vol. 93, no. 1, pp. 62–71, 2009. View at Publisher · View at Google Scholar · View at PubMed
  142. D. Fell and R. D. Steele, “Modification of hepatic folate metabolism in rats fed excess retinol,” Life Sciences, vol. 38, no. 21, pp. 1959–1965, 1986.
  143. A. Bayrak, T. Bayrak, E. Demirpence, and K. Kilinc, “Differential hydrolysis of homocysteine thiolactone by purified human serum 192Q and 192R PON1 isoenzymes,” Journal of Chromatography B, vol. 879, no. 1, pp. 49–55, 2011. View at Publisher · View at Google Scholar · View at PubMed
  144. L. V. Gatica, V. A. Vega, F. Zirulnik, L. B. Oliveros, and M. S. Gimenez, “Alterations in the lipid metabolism of rat aorta: effects of vitamin A deficiency,” Journal of Vascular Research, vol. 43, no. 6, pp. 602–610, 2006. View at Publisher · View at Google Scholar · View at PubMed
  145. Y. W. Lin, L. M. Lien, T. S. Yeh, H. M. Wu, Y. L. Liu, and R. H. Hsieh, “9-cis retinoic acid induces retinoid X receptor localized to the mitochondria for mediation of mitochondrial transcription,” Biochemical and Biophysical Research Communications, vol. 377, no. 2, pp. 351–354, 2008. View at Publisher · View at Google Scholar · View at PubMed
  146. J. Amengual, J. Ribot, M. L. Bonet, and A. Palou, “Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice,” Obesity, vol. 16, no. 3, pp. 585–591, 2008. View at Publisher · View at Google Scholar · View at PubMed
  147. B. Trojanowicz, C. Sekulla, K. Lorenz et al., “Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma,” Molecular and Cellular Endocrinology, vol. 325, no. 1-2, pp. 110–117, 2010. View at Publisher · View at Google Scholar · View at PubMed
  148. S. Giera, A. Braeuning, C. Kohle, et al., “Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver,” The Journal of Toxicological Sciences, vol. 115, no. 1, pp. 22–33, 2010. View at Publisher · View at Google Scholar · View at PubMed
  149. C. Jimenez, I. Leets, R. Puche et al., “A single dose of vitamin A improves haemoglobin concentration, retinol status and phagocytic function of neutrophils in preschool children,” British Journal of Nutrition, vol. 103, no. 6, pp. 798–802, 2010. View at Publisher · View at Google Scholar · View at PubMed
  150. S. Y. Lee, S. Liu, R. M. Mitchell, et al., “HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A”. View at Publisher · View at Google Scholar · View at PubMed
  151. W. Samuel, R. K. Kutty, S. Nagineni, C. Vijayasarathy, R. A. S. Chandraratna, and B. Wiggert, “N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153,” Journal of Cellular Physiology, vol. 209, no. 3, pp. 854–865, 2006. View at Publisher · View at Google Scholar · View at PubMed
  152. K. I. Mills, L. J. Woodgate, A. F. Gilkes et al., “Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14,” Biochemical and Biophysical Research Communications, vol. 263, no. 2, pp. 294–300, 1999. View at Publisher · View at Google Scholar · View at PubMed
  153. K. P. Tan, K. Kosuge, M. Yang, and S. Ito, “NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity,” Free Radical Biology and Medicine, vol. 45, no. 12, pp. 1663–1673, 2008. View at Publisher · View at Google Scholar · View at PubMed
  154. F. Zhao, T. Wu, A. Lau et al., “Nrf2 promotes neuronal cell differentiation,” Free Radical Biology and Medicine, vol. 47, no. 6, pp. 867–879, 2009. View at Publisher · View at Google Scholar · View at PubMed
  155. K. K. Kiningham, Z. A. Cardozo, C. Cook et al., “All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-κB,” Free Radical Biology and Medicine, vol. 44, no. 8, pp. 1610–1616, 2008. View at Publisher · View at Google Scholar · View at PubMed
  156. T. Cadoudal, M. Glorian, A. Massias, F. Fouque, C. Forest, and C. Benelli, “Retinoids upregulate phosphoenolpyruvate carboxykinase and glyceroneogenesis in human and rodent adipocytes,” Journal of Nutrition, vol. 138, no. 6, pp. 1004–1009, 2008.
  157. H. B. Everts, D. O. Claassen, C. L. Hermoyian, and C. D. Berdanier, “Nutrient-gene interactions: dietary vitamin A and mitochondrial gene expression,” IUBMB Life, vol. 53, no. 6, pp. 295–301, 2002. View at Publisher · View at Google Scholar · View at PubMed
  158. Y. Y. Xu, Y. Lu, K. Y. Fan, and Z. H. Shen, “Apoptosis induced by all-trans retinoic acid in N- acetylglucosaminyltransferase V repressed human hepatocarcinoma cells is mediated through endoplasmic reticulum stress,” Journal of Cellular Biochemistry, vol. 100, no. 3, pp. 773–782, 2007. View at Publisher · View at Google Scholar · View at PubMed
  159. S. W. Bahouth, M. J. Beauchamp, and E. A. Park, “Identification of a retinoic acid response domain involved in the activation of the β-adrenergic receptor gene by retinoic acid in F9 teratocarcinoma cells,” Biochemical Pharmacology, vol. 55, no. 2, pp. 215–225, 1998. View at Publisher · View at Google Scholar
  160. L. Liu, F. Derguini, and L. J. Gudas, “Metabolism and regulation of gene expression by 4-oxoretinol versus all-trans retinoic acid in normal human mammary epithelial cells,” Journal of Cellular Physiology, vol. 220, no. 3, pp. 771–779, 2009. View at Publisher · View at Google Scholar · View at PubMed
  161. S. M. Salih, M. Jamaluddin, S. A. Salama, A. A. Fadl, M. Nagamani, and A. Al-Hendy, “Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome,” Fertility and Sterility, vol. 89, no. 5, pp. 1414–1421, 2008. View at Publisher · View at Google Scholar · View at PubMed
  162. S. Sharma and M. F. Notter, “Characterization of neurotransmitter phenotype during neuronal differentiation of embryonal carcinoma cells,” Developmental Biology, vol. 125, no. 2, pp. 246–254, 1988.
  163. X. Castell, M. F. Diebler, M. Tomasi et al., “More than one way to toy with ChAT and VAChT,” Journal of Physiology Paris, vol. 96, no. 1-2, pp. 61–72, 2002. View at Publisher · View at Google Scholar
  164. M. Nilbratt, L. Friberg, M. Mousavi, A. Marutle, and A. Nordberg, “Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells,” Journal of Neuroscience Research, vol. 85, no. 3, pp. 504–514, 2007. View at Publisher · View at Google Scholar · View at PubMed
  165. C. H. P. Ong, Z. He, L. Kriazhev, X. Shan, R. G. E. Palfree, and A. Bateman, “Regulation of progranulin expression in myeloid cells,” American Journal of Physiology, vol. 291, no. 6, pp. R1602–R1612, 2006. View at Publisher · View at Google Scholar · View at PubMed
  166. A. Oikarinen, T. Vuorio, J. Makela, and E. Vuorio, “13-cis retinoic acid and dexamethasone modulate the gene expression of epidermal growth factor receptor and fibroblast proteoglycan 40 core protein in human skin fibroblasts,” Acta Dermato-Venereologica, vol. 69, no. 6, pp. 466–469, 1989.
  167. C. Chang, X. H. Chen, P. Y. Kong et al., “In vitro effect of all-trans retinoic acid on cell adhesion molecule expression and adhesion capacity of bone marrow stromal cells in patients received peripheral blood stem cell transplantation,” Journal of experimental hematology / Chinese Association of Pathophysiology, vol. 14, no. 4, pp. 768–772, 2006.
  168. M. R. Davies, L. R. Ribeiro, M. Downey-Jones, M. R. C. Needham, C. Oakley, and J. Wardale, “Ligands for retinoic acid receptors are elevated in osteoarthritis and may contribute to pathologic processes in the osteoarthritic joint,” Arthritis and Rheumatism, vol. 60, no. 6, pp. 1722–1732, 2009. View at Publisher · View at Google Scholar · View at PubMed
  169. S. Hatakeyama, S. Hayashi, Y. Yoshida et al., “Retinoic acid disintegrated desmosomes and hemidesmosomes in stratified oral keratinocytes,” Journal of Oral Pathology and Medicine, vol. 33, no. 10, pp. 622–628, 2004. View at Publisher · View at Google Scholar · View at PubMed
  170. K. Okumura, Y. Hosoe, and N. Nakajima, “c-Jun and Sp1 family are critical for retinoic acid induction of the lamin A/C retinoic acid-responsive element,” Biochemical and Biophysical Research Communications, vol. 320, no. 2, pp. 487–492, 2004. View at Publisher · View at Google Scholar · View at PubMed
  171. Y. Fang, X. Zhou, M. Lin et al., “The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation,” Cancer Biology and Therapy, vol. 10, no. 11, pp. 1157–1167, 2010. View at Publisher · View at Google Scholar
  172. J. Liu, A. P. Li, C. P. Li, Z. D. Zhang, and J. W. Zhou, “The role of reactive oxygen species in N-[4-hydroxyphenyl] retinamide induced apoptosis in bladder cancer cell lineT24,” Chinese journal of industrial hygiene and occupational diseases, vol. 23, no. 3, pp. 191–194, 2005.
  173. L. T. Lee, K. C. Tan-Un, and B. K. Chow, “Retinoic acid-induced human secretin gene expression in neuronal cells is mediated by cyclin-dependent kinase 1,” Annals of the New York Academy of Sciences, vol. 1070, pp. 393–398, 2006. View at Publisher · View at Google Scholar · View at PubMed
  174. K. A. Latif, I. Amla, and P. B. Rao, “Urinary excretion of arylsulfatases in malnourished/vitamin A deficient children,” Clinica Chimica Acta, vol. 96, no. 1-2, pp. 131–138, 1979.
  175. K. Kasashima, K. Terashima, K. Yamamoto, E. Sakashita, and H. Sakamoto, “Cytoplasmic localization is required for the mammalian ELAV-like protein HuD to induce neuronal differentiation,” Genes to Cells, vol. 4, no. 11, pp. 667–683, 1999.
  176. A. Kihara, M. Ikeda, Y. Kariya, E. Y. Lee, Y. M. Lee, and Y. Igarashi, “Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm,” Journal of Biological Chemistry, vol. 278, no. 16, pp. 14578–14585, 2003. View at Publisher · View at Google Scholar · View at PubMed
  177. J. A. Dembowski and P. J. Grabowski, “The CUGBP2 splicing factor regulates an ensemble of branchpoints from perimeter binding sites with implications for autoregulation,” PLoS Genetics, vol. 5, no. 8, Article ID e1000595, 2009. View at Publisher · View at Google Scholar · View at PubMed
  178. T. M. Chlon, D. A. Taffany, J. Welsh, and M. J. Rowling, “Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells,” Journal of Nutrition, vol. 138, no. 7, pp. 1323–1328, 2008.
  179. B. A. Kudriashov, A. M. Ul'ianov, G. G. Bazaz'ian, and N. P. Sytina, “Factor XIII activity in the presence of suppression of the function of the anticoagulant system and its restoration in animals on an atherogenic ration,” Voprosy pitaniia, no. 5, pp. 54–57, 1976.
  180. C. Puppin, F. Puglisi, L. Pellizzari et al., “HEX expression and localization in normal mammary gland and breast carcinoma,” BMC Cancer, vol. 6, article 192, 2006. View at Publisher · View at Google Scholar · View at PubMed
  181. D. C. Knutson and M. Clagett-Dame, “atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion,” Archives of Biochemistry and Biophysics, vol. 477, no. 1, pp. 163–174, 2008. View at Publisher · View at Google Scholar · View at PubMed
  182. Y. Chen, R. P. Sharma, R. H. Costa, E. Costa, and D. R. Grayson, “On the epigenetic regulation of the human reelin promoter,” Nucleic Acids Research, vol. 30, no. 13, pp. 2930–2939, 2002.
  183. L. Russell, H. Naora, and H. Naora, “Down-regulated RPS3a/nbl expression during retinoid-induced differentiation of HL-60 cells: a close association with diminished susceptibility to actinomycin D-stimulated apoptosis,” Cell Structure and Function, vol. 25, no. 2, pp. 103–113, 2000. View at Publisher · View at Google Scholar
  184. J. Zhang, L. P. Song, Y. Huang, Q. Zhao, K. W. Zhao, and G. Q. Chen, “Accumulation of hypoxia-inducible factor-1α protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid,” Haematologica, vol. 93, no. 10, pp. 1480–1487, 2008. View at Publisher · View at Google Scholar · View at PubMed
  185. M. Takehashi, S. Tanaka, T. Stedeford et al., “Expression of septin 3 isoforms in human brain,” Gene Expression, vol. 11, no. 5-6, pp. 271–278, 2004.
  186. K. Ono and M. Yamada, “Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases,” Neurobiology of Disease, vol. 25, no. 2, pp. 446–454, 2007.
  187. F. Leypoldt, M. Flajolet, and A. Methner, “Neuronal differentiation of cultured human NTERA-2cl.D1 cells leads to increased expression of synapsins,” Neuroscience Letters, vol. 324, no. 1, pp. 37–40, 2002. View at Publisher · View at Google Scholar
  188. Z. J. Sahab, M. D. Hall, L. Zhang, A. K. Cheema, and S. W. Byers, “Tumor suppressor RARRES1 regulates DLG2, PP2A, VCP, EB1, and Ankrd26,” Journal of Cancer, vol. 1, pp. 14–22, 2010.
  189. G. de Chiara, M. E. Marcocci, L. Civitelli et al., “APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells,” PLoS ONE, vol. 5, no. 11, 2010. View at Publisher · View at Google Scholar · View at PubMed
  190. R. Piacentini, L. Civitelli, C. Ripoli, et al., “HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons”. View at Publisher · View at Google Scholar · View at PubMed
  191. M. A. Wozniak, R. F. Itzhaki, S. J. Shipley, and C. B. Dobson, “Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation,” Neuroscience Letters, vol. 429, no. 2-3, pp. 95–100, 2007. View at Publisher · View at Google Scholar · View at PubMed
  192. E. Boelen, F. R. Stassen, A. J. van der Ven et al., “Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection,” Acta Neuropathologica, vol. 114, no. 3, pp. 255–261, 2007. View at Publisher · View at Google Scholar · View at PubMed
  193. C. S. Little, C. J. Hammond, A. MacIntyre, B. J. Balin, and D. M. Appelt, “Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice,” Neurobiology of Aging, vol. 25, no. 4, pp. 419–429, 2004. View at Publisher · View at Google Scholar · View at PubMed
  194. L. Thirumangalakudi, A. Prakasam, R. Zhang et al., “High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice,” Journal of Neurochemistry, vol. 106, no. 1, pp. 475–485, 2008. View at Publisher · View at Google Scholar · View at PubMed
  195. R. P. J. Prasanthi, E. Schommer, S. Thomasson, A. Thompson, G. Feist, and O. Ghribi, “Regulation of β-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease,” Mechanisms of Ageing and Development, vol. 129, no. 11, pp. 649–655, 2008. View at Publisher · View at Google Scholar · View at PubMed
  196. S. Sharma, R. P. J. Prasanthi, E. Schommer, G. Feist, and O. Ghribi, “Hypercholesterolemia-induced Aβ accumulation in rabbit brain is associated with alteration in IGF-1 signaling,” Neurobiology of Disease, vol. 32, no. 3, pp. 426–432, 2008. View at Publisher · View at Google Scholar · View at PubMed
  197. C. Ullrich, M. Pirchl, and C. Humpel, “Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits,” Molecular and Cellular Neuroscience, vol. 45, no. 4, pp. 408–417, 2010. View at Publisher · View at Google Scholar · View at PubMed
  198. C. E. Zhang, W. Wei, Y. H. Liu, et al., “Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain,” The American Journal of Pathology, vol. 174, pp. 1481–1491, 2009.
  199. S. Capsoni, G. Ugolini, A. Comparini, F. Ruberti, N. Berardi, and A. Cattaneo, “Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6826–6831, 2000. View at Publisher · View at Google Scholar
  200. H. Kitaguchi, H. Tomimoto, M. Ihara et al., “Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice,” Brain Research, vol. 1294, pp. 202–210, 2009. View at Publisher · View at Google Scholar · View at PubMed
  201. L. Li, X. Zhang, D. Yang, G. Luo, S. Chen, and W. Le, “Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP,” Neurobiology of Aging, vol. 30, pp. 1091–1098, 2009.
  202. C. Zhiyou, Y. Yong, S. Shanquan et al., “Upregulation of BACE1 and β-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease,” Neurochemical Research, vol. 34, no. 7, pp. 1226–1235, 2009. View at Publisher · View at Google Scholar · View at PubMed
  203. R. Pluta, M. Ułamek, and M. Jabłoński, “Alzheimer's mechanisms in ischemic brain degeneration,” Anatomical Record, vol. 292, no. 12, pp. 1863–1881, 2009. View at Publisher · View at Google Scholar · View at PubMed
  204. Z. G. Li, W. Zhang, and A. A. F. Sima, “Alzheimer-like changes in rat models of spontaneous diabetes,” Diabetes, vol. 56, no. 7, pp. 1817–1824, 2007. View at Publisher · View at Google Scholar · View at PubMed
  205. M. Salkovic-Petrisic, F. Tribl, M. Schmidt, S. Hoyer, and P. Riederer, “Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway,” Journal of Neurochemistry, vol. 96, no. 4, pp. 1005–1015, 2006. View at Publisher · View at Google Scholar · View at PubMed
  206. H. Q. Yang, Z. K. Sun, Q. H. Jiang, Q. Shang, and J. Xu, “Effect of estrogen-depletion and 17beta-estradiol replacement therapy upon rat hippocampus beta-amyloid generation,” Chinese Medical Journal, vol. 89, no. 37, pp. 2658–2661, 2009.
  207. J. P. T. Corcoran, P. L. So, and M. Maden, “Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain,” European Journal of Neuroscience, vol. 20, no. 4, pp. 896–902, 2004. View at Publisher · View at Google Scholar · View at PubMed
  208. L. Letenneur, K. Pérès, H. Fleury et al., “Seropositivity to Herpes Simplex Virus antibodies and risk of Alzheimer's disease: a population-based cohort study,” PLoS ONE, vol. 3, no. 11, Article ID e3637, 2008. View at Publisher · View at Google Scholar · View at PubMed
  209. W. R. Lin, D. Shang, and R. F. Itzhaki, “Neurotropic viruses and Alzheimer disease: interaction of herpes simplex type I virus and apolipoprotein E in the etiology of the disease,” Molecular and Chemical Neuropathology, vol. 28, no. 1–3, pp. 135–141, 1996.
  210. C. J. Hammond, L. R. Hallock, R. J. Howanski, D. M. Appelt, C. S. Little, and B. J. Balin, “Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain,” BMC Neuroscience, vol. 11, article 121, 2010. View at Publisher · View at Google Scholar · View at PubMed
  211. K. Shima, G. Kuhlenbäumer, and J. Rupp, “Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?” Medical Microbiology and Immunology, vol. 199, no. 4, pp. 283–289, 2010. View at Publisher · View at Google Scholar · View at PubMed
  212. J. Kountouras, M. Tsolaki, E. Gavalas et al., “Relationship between Helicobacter pylori infection and Alzheimer disease,” Neurology, vol. 66, no. 6, pp. 938–940, 2006. View at Publisher · View at Google Scholar · View at PubMed
  213. M. Malaguarnera, R. Bella, G. Alagona, R. Ferri, A. Carnemolla, and G. Pennisi, “Helicobacter pylori and Alzheimer's disease: a possible link,” European Journal of Internal Medicine, vol. 15, no. 6, pp. 381–386, 2004. View at Publisher · View at Google Scholar · View at PubMed
  214. M. A. Pappolla, T. K. Bryant-Thomas, D. Herbert et al., “Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology,” Neurology, vol. 61, no. 2, pp. 199–205, 2003.
  215. M. M. Mielke, P. P. Zandi, H. Shao et al., “The 32-year relationship between cholesterol and dementia from midlife to late life,” Neurology, vol. 75, no. 21, pp. 1888–1895, 2010. View at Publisher · View at Google Scholar · View at PubMed
  216. J. C. de la Torre, “The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond,” Neurodegenerative Diseases, vol. 7, no. 1–3, pp. 116–121, 2010. View at Publisher · View at Google Scholar · View at PubMed
  217. M. van Oijen, F. J. de Jong, J. C. Witteman, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Atherosclerosis and risk for dementia,” Annals of Neurology, vol. 61, pp. 403–410, 2007.
  218. A. E. Roher, C. Esh, T. A. Kokjohn et al., “Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 11, pp. 2055–2062, 2003. View at Publisher · View at Google Scholar · View at PubMed
  219. A. E. Roher, C. Esh, A. Rahman, T. A. Kokjohn, and T. G. Beach, “Atherosclerosis of cerebral arteries in Alzheimer disease,” Stroke, vol. 35, no. 11, pp. 2623–2627, 2004. View at Publisher · View at Google Scholar · View at PubMed
  220. J. W. Miller, “Homocysteine and Alzheimer's disease,” Nutrition Reviews, vol. 57, no. 4, pp. 126–129, 1999.
  221. E. M. C. Schrijvers, J. C. M. Witteman, E. J. G. Sijbrands, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler, “Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study,” Neurology, vol. 75, no. 22, pp. 1982–1987, 2010. View at Publisher · View at Google Scholar · View at PubMed
  222. C. J. Pike, J. C. Carroll, E. R. Rosario, and A. M. Barron, “Protective actions of sex steroid hormones in Alzheimer's disease,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 239–258, 2009. View at Publisher · View at Google Scholar · View at PubMed
  223. M. I. Geerlings, L. J. Launer, F. H. de Jong et al., “Endogenous estradiol and risk of dementia in women and men: the Rotterdam study,” Annals of Neurology, vol. 53, no. 5, pp. 607–615, 2003. View at Publisher · View at Google Scholar · View at PubMed
  224. G. Ravaglia, P. Forti, F. Maioli et al., “Endogenous sex hormones as risk factors for dementia in elderly men and women,” Journals of Gerontology Series A, vol. 62, no. 9, pp. 1035–1041, 2007.
  225. F. J. Jimenez-Jimenez, J. A. Molina, F. de Bustos, et al., “Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease,” European Journal of Neurology, vol. 6, pp. 495–497, 1999.
  226. C. J. Carter, “APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle,” Neuroscience Letters, vol. 483, no. 2, pp. 96–100, 2010. View at Publisher · View at Google Scholar · View at PubMed
  227. L. Jones, P. A. Holmans, M. L. Hamshere et al., “Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease,” PLoS ONE, vol. 5, no. 11, Article ID e13950, 2010. View at Publisher · View at Google Scholar · View at PubMed
  228. C. J. Carter, “Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis,” Neurochemistry International, vol. 50, no. 1, pp. 12–38, 2007. View at Publisher · View at Google Scholar · View at PubMed
  229. A. C. Naj, G. W. Beecham, E. R. Martin et al., “Dementia revealed: novel chromosome 6 locus for Late-onset Alzheimer disease provides genetic evidence for Folate-pathway abnormalities,” PLoS Genetics, vol. 6, no. 9, 2010. View at Publisher · View at Google Scholar · View at PubMed
  230. C. J. Carter, “Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner,” International Journal of Alzheimer's Disease, vol. 2010, Article ID 140539, 17 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  231. D. Iacono, W. R. Markesbery, M. Gross et al., “The Nun Study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life,” Neurology, vol. 73, no. 9, pp. 665–673, 2009. View at Publisher · View at Google Scholar · View at PubMed
  232. D. A. Snowdon, “Healthy aging and dementia: findings from the Nun Study,” Annals of Internal Medicine, vol. 139, no. 5, pp. 450–454, 2003.
  233. S. L. Tyas, D. A. Snowdon, M. F. Desrosiers, K. P. Riley, and W. R. Markesbery, “Healthy ageing in the Nun Study: definition and neuropathologic correlates,” Age and Ageing, vol. 36, no. 6, pp. 650–655, 2007. View at Publisher · View at Google Scholar · View at PubMed
  234. D. S. Wolf, M. Gearing, D. A. Snowdon, H. Mori, W. R. Markesbery, and S. S. Mirra, “Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun Study,” Alzheimer Disease and Associated Disorders, vol. 13, no. 4, pp. 226–231, 1999.
  235. M. Colucci, S. Cammarata, A. Assini et al., “The number of pregnancies is a risk factor for Alzheimer's disease,” European Journal of Neurology, vol. 13, no. 12, pp. 1374–1377, 2006. View at Publisher · View at Google Scholar · View at PubMed
  236. J. Kountouras, M. Boziki, E. Gavalas et al., “Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease,” Journal of Neurology, vol. 256, no. 5, pp. 758–767, 2009. View at Publisher · View at Google Scholar · View at PubMed
  237. T. A. Ala, R. C. Doss, and C. J. Sullivan, “Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 6, no. 5, pp. 503–508, 2004.
  238. M. Hoffmann, J. Muniz, E. Carroll, and J. De Villasante, “Cryptococcal meningitis misdiagnosed as Alzheimer's disease: complete neurological and cognitive recovery with treatment,” Journal of Alzheimer's Disease, vol. 16, no. 3, pp. 517–520, 2009. View at Publisher · View at Google Scholar · View at PubMed
  239. E. L. Tobinick and H. Gross, “Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration,” Journal of Neuroinflammation, vol. 5, article 2, 2008. View at Publisher · View at Google Scholar · View at PubMed
  240. I. Marie and E. Guglielmino, “Non tuberculous anti-TNF associated opportunistic infections,” Revue de Medecine Interne, vol. 31, no. 5, pp. 353–360, 2010. View at Publisher · View at Google Scholar · View at PubMed
  241. M. C. Morris, D. A. Evans, J. L. Bienias et al., “Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease,” Archives of Neurology, vol. 60, no. 7, pp. 940–946, 2003. View at Publisher · View at Google Scholar · View at PubMed
  242. Y. Gu, J. W. Nieves, Y. Stern, J. A. Luchsinger, and N. Scarmeas, “Food combination and Alzheimer disease risk: a protective diet,” Archives of Neurology, vol. 67, no. 6, pp. 699–706, 2010. View at Publisher · View at Google Scholar · View at PubMed
  243. N. Scarmeas, Y. Stern, R. Mayeux, and J. A. Luchsinger, “Mediterranean diet, Alzheimer disease, and vascular mediation,” Archives of Neurology, vol. 63, no. 12, pp. 1709–1717, 2006. View at Publisher · View at Google Scholar · View at PubMed
  244. B. Wolozin, W. Kellman, P. Ruosseau, G. G. Celesia, and G. Siegel, “Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors,” Archives of Neurology, vol. 57, no. 10, pp. 1439–1443, 2000.
  245. T. F. Hughes, R. Andel, B. J. Small et al., “Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins,” American Journal of Geriatric Psychiatry, vol. 18, no. 5, pp. 413–420, 2010. View at Publisher · View at Google Scholar · View at PubMed
  246. L. M. Bermejo, A. Aparicio, P. Andrés, A. M. López-Sobaler, and R. M. Ortega, “The influence of fruit and vegetable intake on the nutritional status and plasma homocysteine levels of institutionalised elderly people,” Public Health Nutrition, vol. 10, no. 3, pp. 266–272, 2007. View at Publisher · View at Google Scholar · View at PubMed
  247. J. A. Luchsinger, M. X. Tang, J. Miller, R. Green, and R. Mayeux, “Higher folate intake is related to lower risk of Alzheimer's disease in the elderly,” Journal of Nutrition, Health and Aging, vol. 12, no. 9, pp. 648–650, 2008.
  248. P. L. McGeer, M. Schulzer, and E. G. McGeer, “Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies,” Neurology, vol. 47, no. 2, pp. 425–432, 1996.
  249. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993.
  250. H. C. Gérard, E. Fomicheva, J. A. Whittum-Hudson, and A. P. Hudson, “Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells,” Microbial Pathogenesis, vol. 44, no. 4, pp. 279–285, 2008. View at Publisher · View at Google Scholar · View at PubMed
  251. E. P. de Chaves and V. Narayanaswami, “Apolipoprotein E and cholesterol in aging and disease in the brain,” Future Lipidology, vol. 3, no. 5, pp. 505–530, 2008. View at Publisher · View at Google Scholar
  252. R. Elosua, J. M. Ordovas, L. A. Cupples et al., “Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study,” Journal of Lipid Research, vol. 45, no. 10, pp. 1868–1875, 2004. View at Publisher · View at Google Scholar · View at PubMed
  253. H. Minagawa, J. S. Gong, C. G. Jung et al., “Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture,” Journal of Neuroscience Research, vol. 87, no. 11, pp. 2498–2508, 2009. View at Publisher · View at Google Scholar · View at PubMed
  254. H. Xiong, D. Callaghan, A. Jones, et al., “Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production,” Neurobiology of Disease, vol. 29, no. 3, pp. 422–437, 2008.
  255. M. S. Weintraub, S. Eisenberg, and J. L. Breslow, “Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E,” Journal of Clinical Investigation, vol. 80, no. 6, pp. 1571–1577, 1987.
  256. J. H. Powers, B. L. Buster, C. J. Reist et al., “Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1,” Infection and Immunity, vol. 63, no. 4, pp. 1329–1335, 1995.
  257. S. M. Levitz, “Receptor-mediated recognition of Cryptococcus neoformans,” Japanese Journal of Medical Mycology, vol. 43, no. 3, pp. 133–136, 2002.
  258. D. Belstrom, P. Holmstrup, C. Damgaard, et al., “The atherogenicbacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes,” Infection and Immunity, vol. 79, no. 4, pp. 1559–1565, 2011. View at Publisher · View at Google Scholar · View at PubMed
  259. A. R. Kamer, R. G. Craig, A. P. Dasanayake, M. Brys, L. Glodzik-Sobanska, and M. J. de Leon, “Inflammation and Alzheimer's disease: possible role of periodontal diseases,” Alzheimer's and Dementia, vol. 4, no. 4, pp. 242–250, 2008. View at Publisher · View at Google Scholar · View at PubMed
  260. M. Puolakkainen, C. C. Kuo, and L. A. Campbell, “Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells,” Infection and Immunity, vol. 73, no. 8, pp. 4620–4625, 2005. View at Publisher · View at Google Scholar · View at PubMed
  261. F. Tebar, S. K. Bohlander, and A. Sorkin, “Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic,” Molecular Biology of the Cell, vol. 10, no. 8, pp. 2687–2702, 1999.
  262. E. S. Stuart, W. C. Webley, and L. C. Norkin, “Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells,” Experimental Cell Research, vol. 287, no. 1, pp. 67–78, 2003. View at Publisher · View at Google Scholar
  263. C. M. Crump, B. Bruun, S. Bell, L. E. Pomeranz, T. Minson, and H. M. Browne, “Alphaherpesvirus glycoprotein M causes the relocalization of plasma membrane proteins,” Journal of General Virology, vol. 85, no. 12, pp. 3517–3527, 2004. View at Publisher · View at Google Scholar · View at PubMed
  264. A. Fraile-Ramos, T. A. Kohout, M. Waldhoer, and M. Marsh, “Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway,” Traffic, vol. 4, no. 4, pp. 243–253, 2003.
  265. H. Parker, K. Chitcholtan, M. B. Hampton, and J. I. Keenan, “Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells,” Infection and Immunity, vol. 78, no. 12, pp. 5054–5061, 2010. View at Publisher · View at Google Scholar · View at PubMed
  266. M. Hammarstedt, J. Ahlqvist, S. Jacobson, H. Garoff, and A. Fogdell-Hahn, “Purification of infectious human herpesvirus 6A virions and association of host cell proteins,” Virology Journal, vol. 4, article 101, 2007. View at Publisher · View at Google Scholar · View at PubMed
  267. J. Tschopp, A. Chonn, S. Hertig, and L. E. French, “Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8β, and the b domain of C9,” Journal of Immunology, vol. 151, no. 4, pp. 2159–2165, 1993.
  268. R. D. Bell, A. P. Sagare, A. E. Friedman, et al., “Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system,” Journal of Cerebral Blood Flow & Metabolism, vol. 27, no. 5, pp. 909–918, 2007. View at Publisher · View at Google Scholar · View at PubMed
  269. E. Olano-Martin, E. Anil, M. J. Caslake et al., “Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil,” Atherosclerosis, vol. 209, no. 1, pp. 104–110, 2010. View at Publisher · View at Google Scholar · View at PubMed
  270. H. Evrengul, H. Tanriverdi, O. Kuru et al., “Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection,” Helicobacter, vol. 12, no. 4, pp. 298–305, 2007. View at Publisher · View at Google Scholar · View at PubMed
  271. V. Vitvitsky, M. Thomas, A. Ghorpade, H. E. Gendelman, and R. Banerjee, “A functional transsulfuration pathway in the brain links to glutathione homeostasis,” Journal of Biological Chemistry, vol. 281, no. 47, pp. 35785–35793, 2006. View at Publisher · View at Google Scholar · View at PubMed
  272. A. T. Palamara, C. F. Perno, M. R. Ciriolo et al., “Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication,” Antiviral Research, vol. 27, no. 3, pp. 237–253, 1995. View at Publisher · View at Google Scholar
  273. K. Shibayama, J. Wachino, Y. Arakawa, M. Saidijam, N. G. Rutherford, and P. J. Henderson, “Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism,” Molecular Microbiology, vol. 64, no. 2, pp. 396–406, 2007. View at Publisher · View at Google Scholar · View at PubMed
  274. N. Ballatori, S. M. Krance, S. Notenboom, S. Shi, K. Tieu, and C. L. Hammond, “Glutathione dysregulation and the etiology and progression of human diseases,” Biological Chemistry, vol. 390, no. 3, pp. 191–214, 2009. View at Publisher · View at Google Scholar · View at PubMed
  275. O. H. Stanger, H. J. Semmelrock, P. Rehak et al., “Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease,” Atherosclerosis, vol. 162, no. 1, pp. 157–162, 2002. View at Publisher · View at Google Scholar
  276. Y. Sawayama, M. Tatsukawa, S. Maeda, H. Ohnishi, N. Furusyo, and J. Hayashi, “Association of hyperhomocysteinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients,” Journal of Infection and Chemotherapy, vol. 14, no. 3, pp. 232–237, 2008. View at Publisher · View at Google Scholar · View at PubMed
  277. M. Mayr, S. Kiechl, J. Willeit, G. Wick, and Q. Xu, “Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis,” Circulation, vol. 102, no. 8, pp. 833–839, 2000.
  278. J. A. Mohr, H. Long, B. A. McKown, and H. G. Muchmore, “In vitro susceptibility of Cryptococcus neoformans to steroids,” Sabouraudia Journal of Medical and Veterinary Mycology, vol. 10, no. 2, pp. 171–172, 1972.
  279. K. Hosoda, H. Shimomura, S. Hayashi, K. Yokota, K. Oguma, and Y. Hirai, “Anabolic utilization of steroid hormones in Helicobacter pylori,” FEMS Microbiology Letters, vol. 297, no. 2, pp. 173–179, 2009. View at Publisher · View at Google Scholar · View at PubMed
  280. K. Hosoda, H. Shimomura, S. Hayashi, K. Yokota, and Y. Hirai, “Steroid hormones as bactericidal agents to Helicobacter pylori,” FEMS Microbiology Letters, vol. 318, no. 1, pp. 68–75, 2011. View at Publisher · View at Google Scholar · View at PubMed
  281. C. Clement, P. S. Bhattacharjee, H. E. Kaufman, and J. M. Hill, “Heat-induced reactivation of HSV-1 in latent mice: upregulation in the TG of CD83 and other immune response genes and their LAT-ICP0 locus,” Investigative Ophthalmology and Visual Science, vol. 50, no. 6, pp. 2855–2861, 2009. View at Publisher · View at Google Scholar · View at PubMed
  282. R. D. Vicetti Miguel, B. S. Sheridan, S. A. K. Harvey, R. S. Schreiner, R. L. Hendricks, and T. L. Cherpes, “17-β estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent,” Journal of Virology, vol. 84, no. 1, pp. 565–572, 2010. View at Publisher · View at Google Scholar · View at PubMed
  283. J. D. Kriesel, J. Ricigliano, S. L. Spruance, H. H. Garza Jr., and J. M. Hill, “Neuronal reactivation of herpes simplex virus may involve interleukin-6,” Journal of NeuroVirology, vol. 3, no. 6, pp. 441–448, 1997.
  284. S. Noisakran, W. P. Halford, L. Veress, and D. J. J. Carr, “Role of the hypothalamic pituitary adrenal axis and IL-6 in stress- induced reactivation of latent herpes simplex virus type 1,” Journal of Immunology, vol. 160, no. 11, pp. 5441–5447, 1998.
  285. C. L. Wilcox and E. M. Johnson Jr., “Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro,” Journal of Virology, vol. 61, no. 7, pp. 2311–2315, 1987.
  286. V. Camarena, M. Kobayashi, J. Y. Kim et al., “Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons,” Cell Host and Microbe, vol. 8, no. 4, pp. 320–330, 2010. View at Publisher · View at Google Scholar · View at PubMed
  287. B. Jiang, E. Y. Liao, L. M. Tan, R. C. Dai, Z. J. Xiao, and H. J. Liao, “Effects of long-term replacement therapy of compound nylestriol tablet or low-dose 17 beta-estradiol on the expression of nerve growth factor in OVX rat hippocampal formation,” Journal of Central South University, vol. 29, no. 5, pp. 529–533, 2004.
  288. Y. Hashimoto, H. Kawatsura, Y. Shiga, S. Furukawa, and T. Shigeno, “Significance of nerve growth factor content levels after transient forebrain ischemia in gerbils,” Neuroscience Letters, vol. 139, no. 1, pp. 45–46, 1992. View at Publisher · View at Google Scholar
  289. M. K. Aghi, T. C. Liu, S. Rabkin, and R. L. Martuza, “Hypoxia enhances the replication of oncolytic herpes simplex virus,” Molecular Therapy, vol. 17, no. 1, pp. 51–56, 2009. View at Publisher · View at Google Scholar · View at PubMed
  290. Y. X. Sun, L. Minthon, A. Wallmark, S. Warkentin, K. Blennow, and S. Janciauskiene, “Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 16, no. 3, pp. 136–144, 2003. View at Publisher · View at Google Scholar · View at PubMed
  291. J. Kálmán, A. Juhász, G. Laird et al., “Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in Alzheimer's disease,” Acta Neurologica Scandinavica, vol. 96, no. 4, pp. 236–240, 1997.
  292. F. Shalit, B. Sredni, L. Stern, E. Kott, and M. Huberman, “Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients,” Neuroscience Letters, vol. 174, no. 2, pp. 130–132, 1994. View at Publisher · View at Google Scholar
  293. P. Kragsbjerg, T. Vikerfors, and H. Holmberg, “Cytokine responses in patients with pneumonia caused by Chlamydia or Mycoplasma,” Respiration, vol. 65, no. 4, pp. 299–303, 1998.
  294. N. Mehmet, M. Refik, M. Harputluoglu, Y. Ersoy, N. E. Aydin, and B. Yildirim, “Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori,” New Microbiologica, vol. 27, no. 2, pp. 139–148, 2004.
  295. D. Delfino, L. Cianci, E. Lupis et al., “Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components,” Infection and Immunity, vol. 65, no. 6, pp. 2454–2456, 1997.
  296. C. W. Huang, C. C. Lui, W. N. Chang, C. H. Lu, Y. L. Wang, and C. C. Chang, “Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease,” Journal of Clinical Neuroscience, vol. 16, no. 10, pp. 1283–1286, 2009. View at Publisher · View at Google Scholar · View at PubMed
  297. K. L. Davis, B. M. Davis, B. S. Greenwald, et al., “Cortisol and Alzheimer's disease. I: basal studies,” American Journal of Psychiatry, vol. 143, no. 3, pp. 300–305, 1986.
  298. M. A. Wozniak, A. P. Mee, and R. F. Itzhaki, “Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques,” Journal of Pathology, vol. 217, no. 1, pp. 131–138, 2009. View at Publisher · View at Google Scholar · View at PubMed
  299. E. D. Toffanello, E. M. Inelmen, N. Minicuci et al., “Ten-year trends in vitamin intake in free-living healthy elderly people: the risk of subclinical malnutrition,” Journal of Nutrition, Health and Aging, vol. 15, no. 2, pp. 99–103, 2011. View at Publisher · View at Google Scholar
  300. R. D. Semba, “The role of vitamin A and related retinoids in immune function,” Nutrition Reviews, vol. 56, no. 1, pp. S38–S48, 1998.
  301. C. E. Isaacs, R. Kascsak, R. K. Pullarkat, W. Xu, and K. Schneidman, “Inhibition of herpes simplex virus replication by retinoic acid,” Antiviral Research, vol. 33, no. 2, pp. 117–127, 1997. View at Publisher · View at Google Scholar
  302. C. E. Isaacs, W. Xu, R. K. Pullarkat, and R. Kascsak, “Retinoic acid reduces the yield of herpes simplex virus in Vero cells and alters the N-glycosylation of viral envelope proteins,” Antiviral Research, vol. 47, no. 1, pp. 29–40, 2000. View at Publisher · View at Google Scholar
  303. M. Puolakkainen, A. Lee, T. Nosaka, H. Fukushi, C. C. Kuo, and L. A. Campbell, “Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors,” Microbial Pathogenesis, vol. 44, no. 5, pp. 410–416, 2008. View at Publisher · View at Google Scholar · View at PubMed
  304. H. Sjunnesson, E. Sturegård, R. Willén, and T. Wadström, “High intake of selenium, β-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig,” Comparative Medicine, vol. 51, no. 5, pp. 418–423, 2001.
  305. C. Monari, S. Bevilacqua, M. Piccioni et al., “A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production,” Journal of Immunology, vol. 183, no. 1, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at PubMed
  306. A. Limpach, M. Dalton, R. Miles, and P. Gadson, “Homocysteine inhibits retinoic acid synthesis: a mechanism for homocysteine-induced congenital defects,” Experimental Cell Research, vol. 260, no. 1, pp. 166–174, 2000. View at Publisher · View at Google Scholar · View at PubMed
  307. K. A. Tanghe, T. A. Garrow, and K. L. Schalinske, “Triiodothyronine treatment attenuates the induction of hepatic glycine N-methyltransferase by retinoic acid and elevates plasma homocysteine concentrations in rats,” Journal of Nutrition, vol. 134, no. 11, pp. 2913–2918, 2004.
  308. D. K. Smith, J. M. Greene, S. B. Leonard, T. T. Kuske, D. S. Feldman, and E. B. Feldman, “Vitamin A in hypercholesterolemia,” American Journal of the Medical Sciences, vol. 304, no. 1, pp. 20–24, 1992.
  309. S. J. Soscia, J. E. Kirby, K. J. Washicosky, et al., “The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide,” PLoS ONE, vol. 5, no. 3, Article ID e9505, 2010. View at Publisher · View at Google Scholar · View at PubMed
  310. T. Kawamata, I. Tooyama, T. Yamada, D. G. Walker, and P. L. McGeer, “Lactotransferrin immunocytochemistry in Alzheimer and normal human brain,” American Journal of Pathology, vol. 142, no. 5, pp. 1574–1585, 1993.
  311. W. J. Lukiw, J. G. Cui, L. Y. Yuan, et al., “Acyclovir or Abeta42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells,” Neuroreport, vol. 21, no. 14, pp. 922–927, 2010. View at Publisher · View at Google Scholar · View at PubMed
  312. J. H. Sohn, J. O. So, H. J. Hong et al., “Identification of autoantibody against beta-amyloid peptide in the serum of elderly,” Frontiers in Bioscience, vol. 14, pp. 3879–3883, 2009.
  313. S. Paul, S. Planque, and Y. Nishiyama, “Immunological origin and functional properties of catalytic autoantibodies to amyloid β peptide,” Journal of Clinical Immunology, vol. 30, supplement 1, pp. 43–49, 2010. View at Publisher · View at Google Scholar · View at PubMed
  314. J. Miklossy, K. Khalili, L. Gern et al., “Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease,” Journal of Alzheimer's Disease, vol. 6, no. 6, pp. 639–649, 2004.
  315. W. R. Lin, M. A. Wozniak, R. J. Cooper, G. K. Wilcock, and R. F. Itzhaki, “Herpesviruses in brain and Alzheimer's disease,” Journal of Pathology, vol. 197, pp. 395–402, 2002.
  316. J. Kountouras, M. Boziki, E. Gavalas et al., “Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease,” International Journal of Neuroscience, vol. 119, no. 6, pp. 765–777, 2009. View at Publisher · View at Google Scholar · View at PubMed
  317. J. Choi, S. Y. Lee, K. Kim, and B. K. Choi, “Identification of immunoreactive epitopes of the Porphyromonas gingivalis heat shock protein in periodontitis and atherosclerosis,” Journal of Periodontal Research, vol. 46, no. 2, pp. 240–245, 2011. View at Publisher · View at Google Scholar · View at PubMed
  318. B. F. Roy, T. Sunderland, D. L. Murphy, and J. M. Morihisa, “Antibody for nerve growth factor detected in patients with Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 540, pp. 398–400, 1988.
  319. P. Foley, H. F. Bradford, M. Docherty et al., “Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease,” Journal of Neurology, vol. 235, no. 8, pp. 466–471, 1988.
  320. J. M. Serot, M. C. Bene, B. Gobert, D. Christmann, B. Leheup, and G. C. Faure, “Antibodies to choroid plexus in senile dementia of Alzheimer's disease,” Journal of Clinical Pathology, vol. 45, no. 9, pp. 781–783, 1992.
  321. B. S. Kingsley, F. Gaskin, and S. M. Fu, “Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease,” Journal of Neuroimmunology, vol. 19, no. 1-2, pp. 89–99, 1988.
  322. D. Kanduc, A. Stufano, G. Lucchese, and A. Kusalik, “Massive peptide sharing between viral and human proteomes,” Peptides, vol. 29, no. 10, pp. 1755–1766, 2008. View at Publisher · View at Google Scholar · View at PubMed
  323. B. Trost, A. Kusalik, G. Lucchese, and D. Kanduc, “Bacterial peptides are intensively present throughout the human proteome,” Self/Nonself, vol. 1, no. 1, pp. 71–74, 2010. View at Publisher · View at Google Scholar · View at PubMed
  324. B. Trost, G. Lucchese, A. Stufano, M. Bickis, A. Kusalik, and D. Kanduc, “No human protein is exempt from bacterial motifs, not even one,” Self/Nonself, vol. 1, no. 4, pp. 328–334, 2010. View at Publisher · View at Google Scholar · View at PubMed
  325. R. Jonsson, B. Nakken, A. K. Halse, K. Skarstein, K. Brokstad, and H. J. Haga, “Heredity and immunology in Sjogren's syndrome,” Tidsskr Nor Lægeforen, vol. 120, no. 7, pp. 811–814, 2000.
  326. D. Phillips, L. Prentice, M. Upadhyaya et al., “Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin—studies in families not selected for autoimmune thyroid disease,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 5, pp. 973–975, 1991.
  327. W. M. Pardridge, “Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses,” Bioconjugate Chemistry, vol. 19, no. 7, pp. 1327–1338, 2008. View at Publisher · View at Google Scholar · View at PubMed
  328. D. L. Mallery, W. A. McEwan, S. R. Bidgood, G. J. Towers, C. M. Johnson, and L. C. James, “Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21),” in Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 46, pp. 19985–19990, November 2010. View at Publisher · View at Google Scholar · View at PubMed
  329. D. Vacirca, F. Delunardo, P. Matarrese et al., “Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease”. View at Publisher · View at Google Scholar · View at PubMed
  330. W. B. Grant, “Dietary links to Alzheimer's disease: 1999 Update,” Journal of Alzheimer's Disease, vol. 1, no. 4-5, pp. 197–201, 1999.
  331. L. B. Lopez, D. Kritz-Silverstein, and E. Barrett-Connor, “High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study,” Journal of Nutrition, Health and Aging, vol. 15, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar
  332. J. F. Quinn, R. Raman, R. G. Thomas et al., “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial,” Journal of the American Medical Association, vol. 304, no. 17, pp. 1903–1911, 2010. View at Publisher · View at Google Scholar · View at PubMed
  333. S. A. Frautschy and G. M. Cole, “What was lost in translation in the DHA trial is whom you should intend to treat,” Alzheimer's Research & Therapy, vol. 3, article 2, 2011.
  334. Q. Dai, A. R. Borenstein, Y. Wu, J. C. Jackson, and E. B. Larson, “Fruit and vegetable juices and Alzheimer's disease: the Kame Project,” American Journal of Medicine, vol. 119, no. 9, pp. 751–759, 2006. View at Publisher · View at Google Scholar · View at PubMed